EF
ONC

Empowered Funds’s BeOne Medicines Ltd ONC Stock Holding History

Empowered Funds’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-676
Closed -$201K – 2313
2026
Q1 		$201K Buy
+676
New +$219K ﹤0.01% 2023
2025
Q1 		– Sell
-1,192
Closed -$220K – 1828
2024
Q4 		$220K Buy
+1,192
New +$244K ﹤0.01% 1473

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Empowered Funds's ONC Position: Q2 2026 in Review

Empowered Funds sold out of BeOne Medicines Ltd (ONC) in Q2 2026, closing a stake of 676 shares — an estimated $201K sold.

Empowered Funds first reported a position in ONC in Q4 2024 and held it in 2 quarters. The position peaked at $220K in Q4 2024. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Empowered Funds reported no remaining BeOne Medicines Ltd position as of Q2 2026 after selling out during the quarter.
  • Empowered Funds sold 676 BeOne Medicines Ltd shares in Q2 2026, an estimated $201K.
  • Empowered Funds first reported a position in BeOne Medicines Ltd in Q4 2024 and held it in 2 quarters.
  • Empowered Funds's BeOne Medicines Ltd position peaked at $220K in Q4 2024.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.